Difference between revisions of "Sertznig P, et al. Dermatol. Endocrinol. (2011) cited as Ref 383 in DOI: 10.1038/s41392-020-0110-5 (Q9646)"
Jump to navigation
Jump to search
(Created claim: Second Author string (P150): Reichrath J, #quickstatements; #temporary_batch_1589998140706) |
(Created claim: DOI Identifier (P138): 10.4161/derm.15025, #quickstatements; #temporary_batch_1590000649558) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.4161/derm.15025 / rank | |||
| + | Normal rank | ||
Revision as of 18:59, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sertznig P, et al. Dermatol. Endocrinol. (2011) cited as Ref 383 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sertznig P
0 references
Reichrath J
0 references
